European Pharmaceutical Review

FEBRUARY 1, 2024

What are the top three trends impacting the cardiovascular drug development space today? Michael was the cofounding Chief Medical Officer of Omthera Pharmaceuticals in 2008. We are hopeful that NewAmsterdam Pharma is part of that solution with obicetrapib.”

Documentation 97

Documentation Diabetes Pharmaceutical Companies Pharmaceutical Companies 97

Express Pharma

SEPTEMBER 6, 2023

In a bid to resolve both physical and financial restrictions inhibiting equitable access to quality medicines, the Jan Aushadhi scheme was launched in 2008 and envisaged the setting up of dedicated Janaushadhi Kendras to provide quality generic medicines at capped prices for the general public.

Insurance Coverage and Processing 59

Insurance Coverage and Processing Biosimilars Generic Medicine Drug Pricing 59

Pharmaceutical Technology

JULY 23, 2008

The world’s biggest pharmaceutical company Pfizer announced in June 2008 that it would be putting its “full scope and scale” behind a push into the cancer market. ” “Between 2003 and 2005 global sales for cancer-treating drugs grew by 40%.” So what’s driving the growth?

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Compounding Biosimilars 40

pharmaphorum

SEPTEMBER 18, 2020

However, it withdrew its neuropharmacological drug, Zelmid, which was an SSRI, due to concerns over side effects only a year after it was introduced in 1982. In 1990, the US Food and Drug Administration (FDA) requested Astra to change Losec’s brand name to Prilosec, to avoid confusion with Sanofi-Aventis’ diuretic, Lasix (furosemide).

Vaccines 116

Vaccines Pharmaceutical Companies Pharmaceutical Companies Drug Development 116

Pharmaceutical Technology

AUGUST 26, 2008

In December 2006 it acquired MacroMed Inc, a privately owned speciality drug development and manufacturing company based in the US, for its lead product OncoGel™ for the treatment of oesophageal and brain cancers. The DEEP study results, along with data from further analyses, are under review by a potential licensing partner.

Pharmaceutical Companies 40

Pharmaceutical Companies Pharmaceutical Companies Vaccines Drug Development 40

PharmaShots

JANUARY 31, 2023

Shots: Immutable capital demands and high-spending drug development plans are the most common drivers in encouraging fully-fledged private healthcare companies to go public. Founded Year: 2008 No. In Sep’22 stakeholders exercised 0.7M tradable warrants and 0.3M non-tradable warrants for the gross proceeds of $7.7M.

Vaccines 40

Vaccines Immunity Immunization Diabetes 40

Putting Patients First Blog

SEPTEMBER 30, 2024

The goal of the rare pediatric disease PRV program is to incentivize drug development for rare pediatric diseases. Medicare and Medicaid Extensions Established in 2008, the goal of the Medicare Improvement Fund is to improve upon the original Medicare program, primarily Parts A and B. Under the CR, the Fund distributes $3.2

Department of Veterans Affairs 98

Department of Veterans Affairs Packaging Drug Development 98

STAT

MARCH 26, 2025

Much of the fanfare for AI in drug development has gone to companies at the pre-clinical stage of the pipeline: those churning up new targets , figuring out how to re-purpose drugs , or designing new molecules and proteins that may make good therapeutics.   Continue to STAT+ to read the full story…

Drug Development 257

Drug Development 257

Pharmaceutical Technology

MAY 29, 2008

Andrew Witty took the helm of pharmaceutical giant GlaxoSmithKline in May 2008. PT: Given recent problems with a safety scare over diabetes drug Avandia and GSK’s guidance for a fall in 2008 earnings, what do you envisage Witty’s top or first priorities will be in the new job?

Drug Pricing 40

Drug Pricing Diabetes Drug Development 40

Pharmaceutical Technology

MARCH 22, 2023

Several drug development trends are driving injectables demand. This includes the rising number of biologic drugs on the market, which are mostly administered parenterally. The number of requirements in the revised Annex 1 has been significantly expanded from the original 2008 version and will come into force on 25 August 2023.

Packaging 52

Packaging Compounding Pharmaceutical Companies Pharmaceutical Companies 52

Pharmaceutical Technology

FEBRUARY 28, 2023

First established in 2008, Rare Disease Day is observed every 28 February, with events set up across more than 100 countries in 2023 to unite the world in raising awareness. Orphan drug development is expanding Change is happening. With similar incentives offered by EU/EEA and UK law, orphan drug development has taken off.

Pharmaceutical Companies 52

Pharmaceutical Companies Pharmaceutical Companies Drug Development Communication 52

Pharmaceutical Technology

NOVEMBER 30, 2022

A vitally important assay used across various stages of drug development and manufacturing, container closure integrity testing (CCIT) involves evaluating packaging systems to determine their ability to protect the stability and sterility of pharmaceutical products. The evolution of CCIT.

Drug Development 52

Drug Development Packaging Communication 52

Pharmaceutical Technology

FEBRUARY 20, 2023

On the other hand, a lack of diversity in clinical trial populations, particularly when the disease population is significantly underrepresented, greatly diminishes the quality of data obtained for drug safety and efficacy profiles. This may sound obvious, but it is still a major hurdle in drug development.

Vaccines 52

Vaccines Communication Immunity Immunization 52